Anson Funds Management LP

Holdings History for SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS)

Symbol: SLS on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 7,481,178 shares
Security Ownership %: 4.9%

Shares, Excluding Options vs Price

Value, Excluding Options

Anson Funds Management LP ownership in SELLAS Life Sciences Group, Inc. Common Stock, par value $0.0001 per share (SLS)

17 Feb 2026 - Anson Funds Management LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 7,481,178 shares of SELLAS Life Sciences Group, Inc. Common Stock, par value $0.0001 per share (SLS). This represents 4.9% ownership of the company. In their previous filing dated 14 Nov 2025, Anson Funds Management LP had reported owning 6,032,938 shares, indicating an increase of +24%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Anson Funds Management LP	4.9%	-13%	$31,046,889	7,481,178	+1,448,240	+24%	$4.15	13G/A	31 Dec 2025	17 Feb 2026, 10:34
Anson Funds Management LP	5.7%	+16%	$9,713,030	6,032,938	+806,990	+15%	$1.61	13G	30 Sep 2025	14 Nov 2025, 15:15
Anson Funds Management LP	4.9%	-42%	$9,615,744	5,225,948	-2,353,147	-31%	$1.84	13G/A	30 Jun 2025	14 Aug 2025, 21:43
Anson Funds Management LP	8.3%		$10,610,733	7,579,095			$1.40	13G	31 Mar 2025	15 May 2025, 16:59

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		-1.1%	$0	0	-6,032,938	-100%	$3.55	Q4 2025
30 Sep 2025	1.1%	+1%	$9,713,030	6,032,938	+5,757,938	+2094%	$1.61	Q3 2025
30 Jun 2025	0.11%	-2.9%	$602,250	275,000	-7,304,095	-96%	$2.19	Q2 2025
31 Mar 2025	2%	+1.7%	$8,185,423	7,579,095	+6,386,829	+500%	$1.08	Q1 2025
31 Dec 2024	0.15%	+0.05%	$1,239,957	1,192,266	+398,431	+50%	$1.04	Q4 2024
30 Sep 2024	0.14%	+0.14%	$992,294	793,835	+793,835	NEW	$1.25	Q3 2024
30 Jun 2024		-0.98%	$0	0	-4,832,368	-100%	$3.55	Q2 2024
31 Mar 2024	0.97%	+0.97%	$4,880,692	4,832,368	+4,832,368	NEW	$1.01	Q1 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.